Stanislaw Burzynski

Results: 11



#Item
1January 2012 issue 84 rearranged:Layout 1  a c c e s s o u r

January 2012 issue 84 rearranged:Layout 1 a c c e s s o u r

Add to Reading List

Source URL: www.healthwatch-uk.org

Language: English - Date: 2013-01-16 05:31:19
2Chapter 10  Laws and Regulations Affecting Unconventional Cancer Treatments  CONTENTS

Chapter 10 Laws and Regulations Affecting Unconventional Cancer Treatments CONTENTS

Add to Reading List

Source URL: www.princeton.edu

Language: English - Date: 1996-11-21 08:14:57
3References  References 1. Abbott, B.J., Developmental Therapeutics Program, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human

References References 1. Abbott, B.J., Developmental Therapeutics Program, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human

Add to Reading List

Source URL: www.princeton.edu

Language: English - Date: 1996-11-21 08:15:11
4Chapter 5  Pharmacologic and Biologic Treatments  CONTENTS

Chapter 5 Pharmacologic and Biologic Treatments CONTENTS

Add to Reading List

Source URL: www.princeton.edu

Language: English - Date: 1996-11-21 08:14:54
5Burzynski Research Institute Redacted 2013

Burzynski Research Institute Redacted 2013

Add to Reading List

Source URL: www.fda.gov

Language: English
6May_7_13_PRESS_KIT_2013_no_Contact_info

May_7_13_PRESS_KIT_2013_no_Contact_info

Add to Reading List

Source URL: www.burzynskimovie.com

Language: English - Date: 2013-07-02 06:51:43
7P a g e |1  Responses to January 17th to March 15th, 2013 (FDA-483) Inspectional Observations Observation 1 Failure to monitor the progress of an investigation conducted under your IND. Specifically,

P a g e |1 Responses to January 17th to March 15th, 2013 (FDA-483) Inspectional Observations Observation 1 Failure to monitor the progress of an investigation conducted under your IND. Specifically,

Add to Reading List

Source URL: www.burzynskiresearch.com

Language: English - Date: 2013-11-14 10:27:36
8Page |1 Responses to January 7th to March 15th, 2013 (FDA-483) Inspectional Observations Observation 1 An investigation was not conducted in accordance with the signed statement of investigator and investigation plan. Sp

Page |1 Responses to January 7th to March 15th, 2013 (FDA-483) Inspectional Observations Observation 1 An investigation was not conducted in accordance with the signed statement of investigator and investigation plan. Sp

Add to Reading List

Source URL: www.burzynskiclinic.com

Language: English - Date: 2013-11-11 18:52:45
9Stanislaw R Burzynski, MD

Stanislaw R Burzynski, MD

Add to Reading List

Source URL: www.fda.gov

Language: English
10In the Matter of the Complaint Against Stanislaw R. Burzynski MD PhD. Before the Texas State Board of Medical Examiners. Second Amended Complaint[removed]..

In the Matter of the Complaint Against Stanislaw R. Burzynski MD PhD. Before the Texas State Board of Medical Examiners. Second Amended Complaint[removed]..

Add to Reading List

Source URL: www.bioethicswatch.org

- Date: 2008-02-29 00:58:47